Skip to Content

Lipram (pancrelipase) Disease Interactions

There is 1 disease interaction with Lipram (pancrelipase):

Moderate

Pancrelipase (Includes Lipram) ↔ Hyperuricemia

Moderate Potential Hazard, Moderate plausibility

Applies to: Gout, Renal Dysfunction

Porcine-derived pancreatic enzyme products contain purines that may increase blood uric acid levels. Extremely high dosages of exogenous pancreatic enzymes have also been associated with hyperuricosuria and hyperuricemia. Therapy with pancrelipase should be administered cautiously in patients with preexisting hyperuricemia, gout, or renal impairment. Monitoring of serum uric acid levels is recommended.

References

  1. "Product Information. Cotazym-S (pancrelipase)." Organon, West Orange, NJ.
  2. "Product Information. Ultrase (pancrelipase)." Scandipharm Inc, Birmingham, AL.
  3. "Product Information. Ku-zyme (pancrelipase)." Schwarz Pharma, Mequon, WI.
  4. "Product Information. Creon 10 (pancrelipase)." Solvay Pharmaceuticals Inc, Marietta, GA.
  5. "Product Information. Creon 20 (pancrelipase)." Solvay Pharmaceuticals Inc, Marietta, GA.
  6. "Product Information. Pancrease MT (pancrelipase)." McNeil Pharmaceutical, Raritan, NJ.
  7. "Product Information. Viokase (pancrelipase)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
  8. "Product Information. Creon 5 (pancrelipase)." Solvay Pharmaceuticals Inc, Marietta, GA.
  9. "Product Information. Cotazym (pancrelipase)." Organon, West Orange, NJ.
  10. "Product Information. Zymase (pancrelipase)." Organon, West Orange, NJ.
  11. "Product Information. Pancrease (pancrelipase)." McNeil Pharmaceutical, Raritan, NJ.
  12. "Product Information. Ultrase MT (pancrelipase)." Scandipharm Inc, Birmingham, AL.
View all 12 references

Lipram (pancrelipase) drug Interactions

There are 76 drug interactions with Lipram (pancrelipase)

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide